잠시만 기다려 주세요. 로딩중입니다.

Quality of life in inflammatory bowel diseases: it is not all about the bowel

Intestinal Research 2021년 19권 1호 p.45 ~ 52
Keller Ronald, Mazurak Nazar, Fantasia Laura, Fusco Stefano, Malek Nisar P., Wehkamp Jan, Enck Paul, Klag Thomas,
소속 상세정보
 ( Keller Ronald ) - University Hospital Tubingen Department of Internal Medicine
 ( Mazurak Nazar ) - University Hospital Tubingen Department of Internal Medicine
 ( Fantasia Laura ) - University Hospital Tubingen Department of Internal Medicine
 ( Fusco Stefano ) - University Hospital Tubingen Department of Internal Medicine
 ( Malek Nisar P. ) - University Hospital Tubingen Department of Internal Medicine
 ( Wehkamp Jan ) - University Hospital Tubingen Department of Internal Medicine
 ( Enck Paul ) - University Hospital Tubingen Department of Internal Medicine
 ( Klag Thomas ) - University Hospital Tubingen Department of Internal Medicine

Abstract


Background/Aims: The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving QUOL should be one of the main goals of therapy. This study aims to identify factors contributing to good or impaired QUOL.

Methods: Questionnaires addressing health-related QUOL and other psychological and social features were positioned on our institutions’ webpage and on the webpage of the largest self-help group for IBD in Germany. Patients were subdivided according to their QUOL score with a cutoff of <60. We used the Short Inflammatory Bowel Disease Questionnaire, the Assessment of the Demand for Additional Psychological Treatment, and the Fear of Progression Questionnaire Short Form.

Results: High numbers of patients in both subgroups showed an impaired QUOL (87.34% in UC, 91.08% in CD). Active extraintestinal manifestations, smoking, high fear of progression and high demand for psychotherapy were associated with reduced QUOL. In addition, polypharmacological interventions did not result in a good QUOL, but ostomies are linked to improved QUOL especially in CD patients.

Conclusions: Scores used in clinical day-to-day-practice mainly focusing on somatic factors do not sufficiently address important aspects concerning QUOL. Most importantly, extraintestinal manifestations show a hitherto underestimated impact on QUOL.

키워드

Quality of life; Crohn disease; Colitis, ulcerative; Extraintestinal manifestations

원문 및 링크아웃 정보

 

등재저널 정보